Sphingosine 1-phosphate
|
Basic information |
| Metabolite name | Sphingosine 1-phosphate |
 | HMDB0000277 |
 |
C06124 |
 |
5353956 |
| Synonyms | Sphingosine-1-phosphate; |
| No. of studies | 10 |
|
Basic information |
| Metabolite name | Sphingosine 1-phosphate |
| HMDB0000277 |
|
C06124 |
|
5353956 |
| Synonyms | Sphingosine-1-phosphate; |
| No. of studies | 10 |
|
Relationship between Sphingosine 1-phosphate and depression (count: 10) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M104 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M104 | Type2 | CUMS + ZB group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M104 | Type2 | CUMS + BH group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M104 | Type2 | CUMS + fluoxetine group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M569 | Type2 | LPS + HPF group vs. LPS group | Serum | ICR mouse | Down |
| Study M613 | Type2 | CSDS susceptible + imipramine group vs. CSDS + vehicle group | Ventral hippocampus | C57BL/6 J mouse | Down |
| Study M690 | Type2 | CUMS + high dose of Zhi-zi-chi decoction group vs. CUMS group | Serum | Balb/c mouse | Down |
| Study M849 | Type1 | CUMS group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M858 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M867 | Type2 | CUMS + Baihe-Dihuang Tang group vs. CUMS group | Plasma | Sprague-Dawley rat | Unknown |
| Study M869 | Type1 | CUMS group vs. control group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Up |
| Study M936 | Type1 | SD group vs. control group | Faece | Sprague-Dawley rat | Up |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Up |